Brave Asset Management Inc. lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 45.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,991 shares of the medical research company’s stock after selling 2,527 shares during the quarter. […]